Tag Archives: AVEO

Blue Horseshoe Stocks: More Big Winners

Posted on by

The Estee Lauder Companies Inc. EL – Recap

At this point, mentioning that our most recent fresh options idea turned in a great performance seems to be a foregone conclusion. Nearly everything we’ve touched in 2019 with respect to earnings related options ideas has turned to gold.

EL is just the next link in that chain of premium options tradings ideas we’ve delivered to our readers so far this. It was a new idea for yesterday morning’s premarket report, the EL Weekly $145 & $150 Calls,  and both of those strike points produced big-time single-session gains.

The $145′s ran 128% from 5.28 to 12.00, while the $150′s exploded from a low of 1.99 and hit 7.50, for potential intraday profits of up to 276%
_____

Fresh Idea:
GSK Weekly $39.50-40.50 Calls
GM Weekly $39-41 Calls

Travena, Inc. TRVN

We also want to review a call we made on a stock at the end of 2018 that has found success in the early goings of 2019. We highlighted TRVN for observation in our report dated December 28th, and that day, the stock was trading for as little as .40, and it would never fall lower.

The reached .60 around the halfway point through January, and last week, exactly a month following our tag, TRVN kicked into high gear, reaching 1.45; an increase of 263% over our observed low from the morning of our initial alert.

The stock is currently flirting with its 200DMA, and if it can break previous resistance around the 1.50 area, there is a massive gap to the upside. Things could get even more interesting from there.

Extended Watchlist:
PULM, PAYC, CUTX, BRKS, AVEO, CAPR, EYEN, AMPE

Blue Horseshoe Stocks: CSX Review & More

Posted on by

CSX Corp. CSX – Options Review

We presented our readers with an options idea concerning CSX yesterday morning in the wake of the company’s solid quarterly earnings report, the CSX Weekly $65-67.50 Calls.
‘
What followed was an exceptionally bullish session for the railroad giant, which facilitated some really nice intraday multi-bag gain opportunities.

Not surprisingly, big moves were exhibited by every single contract in our designated range of six sets:

$65 Calls– Range: 1.64-4.00 – Max Gain: 144%
$65.50 Calls – Range: 1.42-3.54 – Max Gain: 149%
$66 Calls – Range: .91-3.00 – Max Gain: 230%
$66.50 Calls – Range: .64-2.57 – Max Gain: 301%
$67 Calls – Range: .45-2.02 – Max Gain: 349%
$67.50 Calls – Range: .28-1.65 – Max Gain: 489%

 Walgreens Boots Alliance, Inc. WBA – Recap

Also included in our morning report yesterday were the WBA 08/17 $67.50 & $70 Calls, and those too enjoyed some notable intraday gains for the session.

Despite selecting calls with August expiration, the payoff to this idea was all but instantaneous, with each of our two ideas logging significant intraday runs to the upside. The $67.50′s traded in a range from .93 to 1.45, a gains of 133% while the $70′s went from .40-.65, which works out to a gain of 63%
____________

Fresh Ideas -  We’ll keep the options train rolling with another pair of fresh ideas this morning:

We’ll track the activity in the EBAY Weekly $36-34.50 Puts after the company fell short on Q2 revs, along with the SPDRA S&P 500 ETF (SPY) 07/23 280.50-281.50 Calls for an idea to watch into next week.

Extended Watchlist:
TCP, DM, RCON, LODE, AVEO, CEI, ACIU

Blue Horseshoe Stocks: Options, NLNK Recaps & More

Posted on by

GoPro, Inc. GPRO

We took advantage of the situation with GPRO yesterday after noticing the stock light up the boards in the premarket on the heels of a guidance adjustment.

We set our sights on the GPRO Weekly $9.50 & $10 Calls and both sets of contracts ended up providing traders with a chance at notable intraday gains.

The $9.50′s ran from .13-.90 for a whopping intraday pop of 592%, while the $10′s traded in a range from .47-1.20 for chances at up to 155% profit.


Insmed, Inc. INSM – Update

We’ve also got the pleasure of updating the figures on the options idea we put out on Tuesday after INSM had yet another solid session. The updated ranges on the contracts we selected are quite impressive, including a twelve-bagger, clearly demonstrating why we devote so much energy to options trading in addition to stocks!

The gains that were up for grabs to anyone who was paying attention were as follows:

$27 Calls – Range: .95-4.50 – Max Gain: 373%
$28 Calls – Range:  .25-3.40 – Max Gain: 1260%
$29 Calls – Range: .40-2.75 – Max Gain: 588%
$30 Calls – Range: .50-2.12 – Max Gain: 324%

NewLink Genetics Corp. NLNK

We also had some very good fortune with our call of NLNK yesterday morning, which we caught notice of on our routine morning scan after some abnormal activity cropped up in the premarket.

Despite the fact that it went into the session as a $9+ stock, we still saw a really nice intraday push en route to NLNK going on the books as the NASDAQ’s top mover. We observed as the stock ran from a low of  9.50, traded up for essentially the entire session, and hit a high of 14.48 for a hefty 52% move on the day.

NLNK closed with strength, maintaining well over half its daily advance, so we’ll definitely want to continue to monitor the situation. No matter how you slice it, a single-session gain of 50% from a nearly ten-dollar stock, is nothing short of incredible.

Extended Watchlist:
CLDR, KURA, AVEO, OPGN, EPIX, FUTL,
FRTA(Bottom-Bouncer)

Blue Horseshoe Stocks: AEZS Recap & More

Posted on by
Aeterna Zentaris, Inc. AEZS

It had been quite some time since the last time we mentioned AEZS in one of our reports, but were prompted to do so yesterday, after noticing some unusual premarket activity on our routine morning scan.

It’s certainly a good thing that we did, because the stock became our number one play of the day with an outstanding performance. It also happened to be the NASDAQ’s top gainer of the day. From an early low of 1.48 the stock shot up to a high of 2.80 shortly after 1:30, marking a single-session rip of 89%

The big move came on volume exceeding the monthly average by roughly 40 times, and the stock managed to hold well over half of its gains into the close, so we’ll be sure to leave AEZS on our radar as we head into the end of the week.

Marijuana Company of America, Inc. MCOA

Another point of focus for us yesterday was MCOA, which we signaled the previous morning, and subsequently witnessed a 38% (.02685-.037) upswing. We were mentioning that, along with the fact that an interesting PR had hit newswires which we felt could set the table for further gains, and we were correct in our assumption.

Perhaps also riding the wave of invigoration that has flowed back into the cannabis space as a whole over the past few sessions, MCOA continued its ascent, trading in a range from .0361-.0467 on the day. That was good for an intraday move of 29% and extended our two-session observed range on the stock to a respectable 74%


Sears Holdings Corp. SHLD – Options Idea

We’ve had some good fortune in the past with SHLD, and more specifically, its options chain. This morning, we’re spotting another possible opportunity on that front. The company will now be selling Kenmore appliances via Amazon.com, and as a result, the stock is gapping up over ten percent in premarket trading this morning.

To take advantage of the commotion, we’ll have our eye on the SHLD Weekly $9-10 Calls.

Extended Watchlist:
TEUM, ANY, AVEO, DFFN, HPJ, CAMT, BVXV

Blue Horseshoe Stocks: AVEO Recap & More

Posted on by

AVEO Pharmaceuticals, Inc. AVEO

Swinging back around to discuss AVEO is our top order of business this morning after the stock soared to new highs yesterday. We placed this stock on watch on June 23rd, subsequently mentioning it several times.

On the day of our initial alert, AVEO traded for as little as 1.05 per share, and after multiple weeks in a near-contnual uptrend, the gains have been fantastic. Yesterday AVEO reached new four year highs of 3.19, marking an overall swing of 204%

Volume over the same period has been greatly heightened, and yesterday’s close at 3.15 was a strong one, so even though AVEO has had momentum-mover status for several sessions, we’re going to want to continue to watch it closely.

Inotek Pharmaceuticals, Inc. ITEK

We’re always looking for a good bottom-bouncer, which is why we want to take note of ITEK this morning after disappointing study results on the company’s eye drug sent shares tumbling yesterday.

As we point out on the chart snapshot below, the stock has been beaten back into oversold territory, leaving a big gap on the chart. We’ll place it on watch for the filling of that gap, which from present pricing would spell gains of up to 60%

Extended Watchlist:
ATNM, HK, FOLD, TEUM, JAGX, MSDI, OCUL